Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
B., Oreskovic, I., Ziger, T., Novinscak, T., Krezic, I., Strbe, S., Drinkovic, M., Brkic, F., Popic, J., Skrtic, A., Seiwerth, S., Staresinic, M., Sikiric, P.,
the deprotonated form C 14 H 22 CuN 6 O 4 is also reported in the literature) Molecular weight: approximately 403.9 g/mol (protonated complex) PubChem CID: 378611 (Cu-GHK complex) Lyophilisation & Stability Supplied as a sterile-filtered, lyophilised blue powder under inert gas in a sealed vial
The mechanisms most often cited center on neurotransmitter and receptor modulation
Yet the consequences are unknown Bioavailability: there are four specific metabolic steps necessary to convert cyanocobalamin into one of the coenzyme forms, which is a clear metabolic disadvantage (3) Utilisation problems: certain hereditary diseases, as well as metabolic disorders, prevent the conversion of cyanocoalamin into the active B12 forms (4) Steals methyl groups: cyanocobalamin requires a methyl group to convert into methylcobalamin, which it takes from the important amino acid S-adenosylmethionine (SAM)
